// App-Quantinova.ai

1814 : Retrospective Real-World Analysis of the Primary Safety Outcomes in Venous Thromboembolism of High-Risk Major Bleeding Cancer Patients Receiving Therapeutic Anticoagulation

Researchers

Presenter

  • Eric Brucks Brucks

Principal Investigators

  • Sumana Veeravelli

  • Ritika Halder

  • Francisco Javier Martinez

  • Jorge Andres Leiva

  • Kathylynn Saboda

  • Denise Roe

  • Hani M. Babiker

  • Ali McBride

  • Alejandro Recio-Boiles

Medical Centers

  • Department of Internal Medicine, University of Arizona, Tucson, AZ

  • Strake Jesuit College, Houston, TX

  • Department of Medicine, University of Arizona Medical Center, Tucson, AZ

  • University of Arizona College of Pharmacy, Tucson, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Solid malignancies

Biomarkers

  • Red Blood Cells

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • apixaban

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved